Trade Edwards Lifesciences - EW CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.20 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 73.83 |
| Open | 73.46 |
| 1-Year Change | -4.4% |
| Day's Range | 73.46 - 73.92 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 17, 2024 | 73.83 | 0.26 | 0.35% | 73.57 | 74.31 | 73.20 |
| Dec 16, 2024 | 73.81 | 0.16 | 0.22% | 73.65 | 74.50 | 72.85 |
| Dec 13, 2024 | 73.21 | -0.30 | -0.41% | 73.51 | 73.88 | 72.29 |
| Dec 12, 2024 | 73.89 | 0.93 | 1.27% | 72.96 | 74.69 | 72.96 |
| Dec 11, 2024 | 73.53 | 0.67 | 0.92% | 72.86 | 74.20 | 72.85 |
| Dec 10, 2024 | 73.33 | 2.36 | 3.33% | 70.97 | 73.89 | 70.97 |
| Dec 9, 2024 | 70.83 | -0.67 | -0.94% | 71.50 | 72.42 | 70.54 |
| Dec 6, 2024 | 71.45 | -0.42 | -0.58% | 71.87 | 73.59 | 71.31 |
| Dec 5, 2024 | 72.35 | -0.80 | -1.09% | 73.15 | 74.24 | 71.83 |
| Dec 4, 2024 | 74.12 | 2.83 | 3.97% | 71.29 | 74.43 | 71.29 |
| Dec 3, 2024 | 70.11 | -0.09 | -0.13% | 70.20 | 70.48 | 69.52 |
| Dec 2, 2024 | 70.33 | 0.66 | 0.95% | 69.67 | 70.47 | 69.04 |
| Nov 29, 2024 | 71.26 | 0.31 | 0.44% | 70.95 | 71.45 | 69.92 |
| Nov 27, 2024 | 71.82 | 0.43 | 0.60% | 71.39 | 72.38 | 71.04 |
| Nov 26, 2024 | 71.49 | 0.58 | 0.82% | 70.91 | 72.29 | 70.64 |
| Nov 25, 2024 | 71.08 | 0.40 | 0.57% | 70.68 | 71.34 | 70.06 |
| Nov 22, 2024 | 70.41 | 0.63 | 0.90% | 69.78 | 70.83 | 69.73 |
| Nov 21, 2024 | 70.29 | 0.69 | 0.99% | 69.60 | 70.81 | 68.95 |
| Nov 20, 2024 | 69.47 | -0.78 | -1.11% | 70.25 | 70.25 | 68.18 |
| Nov 19, 2024 | 70.11 | 1.53 | 2.23% | 68.58 | 70.20 | 67.97 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Edwards Lifesciences Company profile
About Edwards Lifesciences Corp
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Edwards Lifesciences Corp revenues increased 19% to $5.23B. Net income increased 83% to $1.5B. Revenues reflect Transcatheter Aortic Valve Replacement segment increase of 20% to $3.42B, Surgical Heart Valve Therapy segment increase of 17% to $889.1M, Critical Care segment increase of 15% to $834.9M, United States segment increase of 18% to $2.96B, Europe segment increase of 26% to $1.19B.
Equity composition
Common Stock $1 Par, 12/10, 350M auth., 117,100,000 issd. less 2,000 shs. in Treas. @ $102M. Insiders control 0.64%. 4/3/00,Company spun off from Baxter International. 05/10, 2-for-1 stock split. 12/15, 2-for-1 stock split.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
One Edwards Way
IRVINE
CALIFORNIA 92614
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com